Table 2.
MK-2206 Adverse Events
| Dose Level (# of Patients) | Adverse Event | Grade I | Grade II | Grade III |
|---|---|---|---|---|
| 200 mg (4) | ||||
| Mucositis | 1 | 2 | ||
| Rash | 1 | 1 | ||
| Pruritus | 2 | |||
| Hyperglycemia | 1 | 1 | ||
| Fever | 1 | |||
| 135 mg (3) | ||||
| Rash | 2 | |||
| Pruritus | 1 | 1 | ||
| 90 mg (5) | ||||
| Mucositis | 1 | 1 | ||
| Rash | 1 | |||
| Hyperglycemia | 1 | |||
| Dry Skin | 2 | |||
| Total (12) | 6 | 7 | 7 | |